Anti-TNF-? formula enhances wound healing

Washington - Topical application of anti-tumor necrosis factor-? (TNF-?) monoclonal antibody (infliximab) produced dramatic improvement with wound closure in chronic, non-healing leg ulcers, said Markus Streit, M.D., department of dermatology, Inselspital, Bern, Switzerland.

Related Videos
Related Content

Metal Implants Can Lead to Allergic Contact Dermatitis

March 25th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Mediterranean Diet May Improve Responses to Immune Checkpoint Blockade for Advanced Melanoma

March 24th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Air Pollution from Wildfire Smoke Can Exacerbate Skin Conditions

March 24th 2023

Highlights from AAD 2023

March 23rd 2023

Metal Implants Can Lead to Allergic Contact Dermatitis

March 25th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Mediterranean Diet May Improve Responses to Immune Checkpoint Blockade for Advanced Melanoma

March 24th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Air Pollution from Wildfire Smoke Can Exacerbate Skin Conditions

March 24th 2023

Highlights from AAD 2023

March 23rd 2023

Metal Implants Can Lead to Allergic Contact Dermatitis

March 25th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Mediterranean Diet May Improve Responses to Immune Checkpoint Blockade for Advanced Melanoma

March 24th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Air Pollution from Wildfire Smoke Can Exacerbate Skin Conditions

March 24th 2023

Highlights from AAD 2023

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.